Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sangamo Therapeutics Inc (NASDAQ:SGMO)

4.30
Delayed Data
As of Apr 24
 +0.25 / +6.17%
Today’s Change
2.65
Today|||52-Week Range
7.60
+40.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues24.1M45.9M39.5M19.4M
 
 
 
 
 
Depreciation And Amortization569.0K549.0K988.0K997.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses50.1M71.9M85.3M91.0M
 
 
 
 
 
Research And Development37.0M56.7M67.1M65.6M
 
 
 
 
 
Total Operating Expenses50.7M72.4M86.3M91.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.5M-26.6M-46.8M-72.6M
 
 
 
 
 
Extraordinary Credit0.000.001.8M0.00
 
 
Extraordinary Charge-160.0K-230.0K-1.9M0.00
 
 
 
 
Other Expenses0.000.00431.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.6M-26.4M-46.4M-71.7M
 
 
 
 
 
Income Taxes0.000.00-5.7M-14.0K
 
 
 
Net Income-26.6M-26.4M-40.7M-71.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.0M67.0M69.8M70.6M
 
 
 
 
 
Shares To Calculate EPS Diluted56.0M67.0M69.8M70.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$0.39-$0.58-$1.02
 
 
 
 
 
EPS Diluted-$0.48-$0.39-$0.58-$1.02